TFAP2A and lung carcinoma: In this study, we for the first time showed that AP2 is an important transcription factor driving USP22 gene expression; and revealed an association of AP2 with USP22 in lung cancer tissues, suggesting AP2 may promotes the progression of lung adenocarcinoma partially via enhancing USP22 expression.